AK

Ajay Kumar Sharma

Active Director Director DIN 10699005
DIN 10699005 First appointment Jul 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value •••• Premium profile

About Ajay Kumar Sharma

Data last updated:

Ajay Kumar Sharma is a Director at Lubbecke Lifesciences Private Limited (since 2024). The company operates in Pharma. Lubbecke Lifesciences Private Limited reported revenue of ₹4.08 Cr (FY 2025).

DIN 10699005
Primary Designation Director
Industry Pharma
First Appointment 08 Jul 2024
Oldest Company Age 2 yrs
Largest company Lubbecke Lifesciences Private Limited · ₹4.08 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Jul 20242023₹4.08 Cr (FY 2025)Active

Board colleagues of Ajay Kumar Sharma

Directorship timeline

Open interactive timeline →
Lubbecke Lifesciences Private Limited
Premium access

Shareholding and investment profile for Ajay Kumar Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajay Kumar Sharma

Ajay Kumar Sharma currently holds 1 directorship: Lubbecke Lifesciences Private Limited (Director, since 08 Jul 2024, revenue ₹4.08 Cr (FY 2025)).

Ajay Kumar Sharma was first appointed on 08 Jul 2024 as Director at Lubbecke Lifesciences Private Limited.

The current boards of Ajay Kumar Sharma's companies include Rajeev Tyagi (Lubbecke Lifesciences Private Limited), Ritu Bhat (Lubbecke Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available